JMJD1C is required for the survival of acute myeloid leukemia by functioning as a coactivator for key transcription factors.

However, the overlap between these sets was only borderline significant ( P = 0.042) ( Fig. 4 E, right), suggesting that this is more likely to reflect secondary effects compared with the coordinately activated gene set.

also in 11,409 other papers